CBD Life Sciences Balance Sheet Health
Financial Health criteria checks 6/6
CBD Life Sciences has a total shareholder equity of $342.2K and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $386.7K and $44.5K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$82.00 |
| Equity | US$342.20k |
| Total liabilities | US$44.54k |
| Total assets | US$386.74k |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CBDL's short term assets ($185.3K) exceed its short term liabilities ($44.5K).
Long Term Liabilities: CBDL has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: CBDL is debt free.
Reducing Debt: CBDL has no debt compared to 5 years ago when its debt to equity ratio was 16%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CBDL has sufficient cash runway for 0 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: CBDL is forecast to have sufficient cash runway for 0 months based on free cash flow estimates, but has since raised additional capital.